Navigate China's Pharma Market: Expert Regulatory Services by DDRegPharma

Are you looking to successfully launch or maintain your pharmaceutical or medical device products in the dynamic Chinese market? DDRegPharma offers comprehensive regulatory affairs consulting services specifically tailored for China, ensuring compliance and accelerating your market access.

Our China Regulatory Services Include:

• NMPA Regulatory Affairs Consulting: Expert guidance through China's National Medical Products Administration (NMPA) requirements.
• Regulatory Strategy Development: Crafting effective strategies for product registration and approval.
• Marketing Authorization Applications: Assisting with new product marketing authorizations.
• Gap Analysis & Remediation: Identifying and addressing compliance gaps in your documentation and processes.
• CMC Advisory: Comprehensive support for Chemistry, Manufacturing, and Controls.
• API & DMF Services: Assistance with Drug Master Files.
• Post-Approval Life Cycle Management: Ensuring ongoing compliance and product longevity.
• eCTD Publishing & Submission Services: Streamlined electronic dossier preparation and submission.
• ANDA and MA Holding Services: Support for Abbreviated New Drug Applications and Marketing Authorizations.
• Regulatory Due Diligence: Thorough assessments to mitigate risks.

Why Choose DDRegPharma?

With deep expertise in China's evolving regulatory environment, our dedicated team provides high-quality, timely, and cost-effective solutions. We help you navigate complex requirements, overcome challenges, and achieve your business objectives.